Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

FDG PET imaging in the evaluation of post-transplant lymphoproliferative disorder following renal transplantation

FDG PET imaging in the evaluation of post-transplant lymphoproliferative disorder following renal transplantation NUCLEAR MEDICINE COMMUNICATIONS O'Conner, A. R., Franc, B. L. 2005; 26 (12): 1107–11

Abstract

To assess the usefulness of fluorodeoxyglucose positron emission tomography (FDG PET) in the evaluation of post-transplant lymphoproliferative disorder (PTLD) following renal transplantation.Staging FDG PET examinations were reviewed in five patients with biopsy proven post-renal allograft PTLD and compared with conventional imaging. Follow-up PET examinations of three patients at various points during their therapy for PTLD were also reviewed and compared with clinical outcome.PET imaging identified all disease sites seen at cross-sectional imaging, clarified sites of uncertain significance and detected additional disease in two out of five patients. Early follow-up imaging impacted PTLD management in two of three patients.In this limited series FDG PET was an effective imaging modality in the staging and follow-up of PTLD.

View details for DOI 10.1097/00006231-200512000-00010

View details for Web of Science ID 000233546000010

View details for PubMedID 16264358